Benzinga - Thu, 11 Feb 2021 17:40:25 -0400
Benzinga - Thu, 11 Feb 2021 05:04:36 -0400
Benzinga - Wed, 10 Feb 2021 06:16:46 -0400
Benzinga - Tue, 09 Feb 2021 17:42:45 -0400
Benzinga - Tue, 09 Feb 2021 13:46:34 -0400
Benzinga - Tue, 09 Feb 2021 13:13:04 -0400
Benzinga - Tue, 09 Feb 2021 09:08:54 -0400
Benzinga - Tue, 09 Feb 2021 08:01:46 -0400
Benzinga - Mon, 08 Feb 2021 17:37:13 -0400
Benzinga - Fri, 05 Feb 2021 05:54:56 -0400
Benzinga - Thu, 04 Feb 2021 14:01:24 -0400
Benzinga - Thu, 04 Feb 2021 13:00:18 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-13
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-19
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ITRMIterum Therapeutics11.03%230.3M

Iterum Therapeutics Company Questions & Answers

Q

How do I buy Iterum Therapeutics (ITRM) stock?

A

You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iterum Therapeutics's (ITRM) main competitors?

A

Other companies in Iterum Therapeutics’s space includes: Xeris Pharmaceuticals (NASDAQ:XERS), Jaguar Health (NASDAQ:JAGX) and Tricida (NASDAQ:TCDA).

Q

What is the target price for Iterum Therapeutics?

A

The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by SVB Leerink on 2020-10-01. The analyst firm set a price target for 1.50 expecting ITRM to fall to within 12 months (a possible -0.66% downside). 4 analyst firms have reported ratings in the last year.

Q

How much is Iterum Therapeutics (ITRM) stock ?

A

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.51 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Iterum Therapeutics (ITRM) dividend?

A

There are no upcoming dividends for Iterum Therapeutics.

Q

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

A
Iterum Therapeutics’s Q1 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for ITRM?

A

There is no upcoming split for Iterum Therapeutics.